Myomectomy During Cesarean Section Is This Aright Decision
1 other identifier
observational
45
0 countries
N/A
Brief Summary
myomectomy was done during cesarean section
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2014
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 15, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 20, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 15, 2019
CompletedFirst Submitted
Initial submission to the registry
April 29, 2020
CompletedFirst Posted
Study publicly available on registry
May 15, 2020
CompletedMay 15, 2020
May 1, 2020
4.6 years
April 29, 2020
May 13, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
difficulty of cesarean myomectomy
according to the site and type of myoma
during the procedure/surgery"
Secondary Outcomes (1)
4concentrations of hemoglobin
during the procedure
Interventions
The myomectomy was done by conventional technique but timing of myomectomy either before or after delivery of the baby varied between different cases .Infusion of oxytocin during the operation and for 24 h later.
Eligibility Criteria
c s with uterine myoma
You may qualify if:
- women with diagnosed uterine myoma prior to pregnancy
- needed cesarean sections for various indications.
- Women with diagnosed uterine myoma during pregnancy and needed cesarean sections for various indications.
- Women with myoma diagnosed incidentally during labour.
You may not qualify if:
- Refusal of the women at any time before and during the operations.
- Cervical myoma.
- Atonic uterus after delivery of the baby.
- Women with bleeding disorders due to medical or obstetric causes.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Benha Universitylead
Related Publications (1)
Ledee-Bataille N, Lapree-Delage G, Taupin JL, Dubanchet S, Frydman R, Chaouat G. Concentration of leukaemia inhibitory factor (LIF) in uterine flushing fluid is highly predictive of embryo implantation. Hum Reprod. 2002 Jan;17(1):213-8. doi: 10.1093/humrep/17.1.213.
PMID: 11756390RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
khalid salama
Benha University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- clinical professor
Study Record Dates
First Submitted
April 29, 2020
First Posted
May 15, 2020
Study Start
August 15, 2014
Primary Completion
March 20, 2019
Study Completion
September 15, 2019
Last Updated
May 15, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will not share
master sheet